Between 2000 and 2016, more than 600,000 people died from drug overdoses. More than half of those deaths involved opioids, according to the U.S. Centers for Disease Control and Prevention (CDC). Although the amount of opioids prescribed is gradually decreasing, it's still too high—about three times as high as in 1999, a CDC report states.
Adaptive deep brain stimulation(aDBS) seemed to effectively control motor symptoms, and was safe and well tolerated, in patients with advanced Parkinson's disease, according to international researchers.
Human brains have to manage an inconceivably massive amount of information. By current estimations, we are offloading, transferring, and storing information upward of 2.5 quintillion bytes a day. In this, humans require a trustable mechanism for recalling and telling their story. And such technology could enable the betterment of the human species.
Topics: Implantable Devices
Cognixion, the neurotech A.I. company with operations in Toronto, Ontario (Canada) and Santa Barbara, CA (USA), announced a $1M Angel Seed Round led by Tom Washing, Founding Partner of Sequel Venture Partners, to create an interface that helps nonverbal people communicate using their mind, powered by AI. The biosignal processing platform will be able to translate brainwave patterns via a BCI (Brain Computer Interface) directly into verbal communication.
Nexeon MedSystems Inc., headquartered in Dallas, Texas, is a medical device company developing a neurostimulator technology platform for the treatment of disorders through the electrical stimulation of neural tissues. The company’s first application of its Nexeon Neurostimulation System will be for the treatment of chronic medical conditions such as Parkinson’s and associated diseases in Europe. The company’s Belgian-based Medi-Line subsidiary provides global medical device outsource manufacturing solutions for existing customers and long term supply contracts with Fortune 50 companies.
Scientists are examining the feasibility of treating autistic children with neuromodulation after a new study showed social impairments can be corrected by brain stimulation.
Technologies to detect brain activity — fine, we’ll come right out and call it mind reading — as well as to change it are moving along so quickly that “a bit of a gold rush is happening, both on the academic side and the corporate side,” Michel Maharbiz of the University of California, Berkeley, told a recent conference at the Massachusetts Institute of Technology. Here are three fast-moving areas of neuroscience we’ll be watching in 2018:
For millions of Americans suffering from debilitating nerve pain, a once-overlooked option has emerged as an alternative to high doses of opioids: implanted medical devices using electricity to counteract pain signals the same way noise-canceling headphones work against sound.
Nexeon Medsytems is a medical device company focused on providing innovative neurostimulation products for patients suffering from debilitating neurological diseases, including Parkinson’s and essential tremor. It was founded in 2005 with the goal of changing how innovative ideas in the medical device industry move from concept to reality, with a focus on creating solutions for clinicians in their pursuit of improving patient outcomes.